Quantum mechanics implementation in drug-design workflows: does it really help?

作者: Olayide A Arodola , Mahmoud ES Soliman

DOI: 10.2147/DDDT.S126344

关键词: PacePharmaceutical industryProcess (engineering)Empirical researchCritical questionDrug discoveryQuantum mechanicsWorkflowProfit (economics)Computer science

摘要: The pharmaceutical industry is progressively operating in an era where development costs are constantly under pressure, higher percentages of drugs demanded, and the drug-discovery process a trial-and-error run. profit that flows with discovery new has always been motivation for to keep up pace abreast endless demand medicines. finding molecule binds target protein using silico tools made computational chemistry valuable tool drug both academic research industry. However, complexity many protein-ligand interactions challenges accuracy efficiency commonly used empirical methods. usefulness quantum mechanics (QM) drug-protein interaction cannot be overemphasized; however, this approach little significance some In review, we discuss recent developments in, application of, QM medically relevant biomolecules. We critically different types QM-based methods their proposed incorporating them into drug-design -discovery workflows while trying answer critical question: real help industry?

参考文章(140)
Kaushik Raha, Martin B. Peters, Kenneth M. Merz, Quantum mechanics in structure-based drug design. Current Opinion in Drug Discovery & Development. ,vol. 9, pp. 370- 379 ,(2006)
Terry R. Stouch, James R. Kenyon, Stephen R. Johnson, Xue-Qing Chen, Arthur Doweyko, Yi Li, In silico ADME/Tox: why models fail. Journal of Computer-aided Molecular Design. ,vol. 17, pp. 83- 92 ,(2003) , 10.1023/A:1025358319677
Murray P. Deutscher, Guide to Protein Purification ,(2009)
Franziska Kriegenburg, Lars Ellgaard, Rasmus Hartmann-Petersen, Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation. FEBS Journal. ,vol. 279, pp. 532- 542 ,(2012) , 10.1111/J.1742-4658.2011.08456.X
Todd J.A. Ewing, Shingo Makino, A. Geoffrey Skillman, Irwin D. Kuntz, DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases Journal of Computer-aided Molecular Design. ,vol. 15, pp. 411- 428 ,(2001) , 10.1023/A:1011115820450
Kathrin Heikamp, Jürgen Bajorath, The Future of Virtual Compound Screening Chemical Biology & Drug Design. ,vol. 81, pp. 33- 40 ,(2013) , 10.1111/CBDD.12054
Mengang Xu, Markus A. Lill, Induced fit docking, and the use of QM/MM methods in docking. Drug Discovery Today: Technologies. ,vol. 10, ,(2013) , 10.1016/J.DDTEC.2013.02.003
Cláudio Nahum Alves, Sergio Martí, Raquel Castillo, Juan Andrés, Vicent Moliner, Iñaki Tuñón, Estanislao Silla, A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid Biophysical Journal. ,vol. 94, pp. 2443- 2451 ,(2008) , 10.1529/BIOPHYSJ.107.107623
Chenzhong Liao, Marc C. Nicklaus, Tautomerism and Magnesium Chelation of HIV-1 Integrase Inhibitors: A Theoretical Study ChemMedChem. ,vol. 5, pp. 1053- 1066 ,(2010) , 10.1002/CMDC.201000039